Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

Efficient detoxification of nerve agents by oxime-assisted reactivation of acetylcholinesterase mutants (CROSBI ID 277699)

Prilog u časopisu | pregledni rad (znanstveni) | međunarodna recenzija

Kovarik, Zrinka ; Maček Hrvat, Nikolina Efficient detoxification of nerve agents by oxime-assisted reactivation of acetylcholinesterase mutants // Neuropharmacology, 171 (2020), 1-7. doi: 10.1016/j.neuropharm.2020.108111

Podaci o odgovornosti

Kovarik, Zrinka ; Maček Hrvat, Nikolina

engleski

Efficient detoxification of nerve agents by oxime-assisted reactivation of acetylcholinesterase mutants

The recent advancements in crystallography and kinetics studies involving reactivation mechanism of acetylcholinesterase (AChE) inhibited by nerve agents have enabled a new paradigm in the search for potent medical countermeasures in case of nerve agents exposure. Poisonings by organophosphorus compounds (OP) that lead to life-threatening toxic manifestations require immediate treatment that combines administration of anticholinergic drugs and an aldoxime as a reactivator of AChE. An alternative approach to reduce the in vivo toxicity of OP centers on the use of bioscavengers against the parent organophosphate. Our recent research showed that site-directed mutagenesis of AChE can enable aldoximes to substantially accelerate the reactivation of OP-enzyme conjugates while dramatically slowing down rates of OP-conjugate dealkylation (aging). Therefore, this review focuses on oxime-assisted catalysis by AChE mutants that provides a potential means for degradation of organophosphates in the plasma before reaching the cellular target site.

antidotes ; cholinesterase ; organophosphates ; oximes ; phosphorylation ; 2-PAM

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

171

2020.

1-7

objavljeno

0028-3908

1873-7064

10.1016/j.neuropharm.2020.108111

Povezanost rada

nije evidentirano

Poveznice
Indeksiranost